Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Publication ,  Conference
Friedman, DR; Davis, PH; Lanasa, MC; Moore, JO; Gockerman, JP; Nelson, T; Bond, KM; Jiang, N; Davis, ED; Allgood, SD; Chen, Y; Sportelli, P ...
Published in: BLOOD
November 19, 2010

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 19, 2010

Volume

116

Issue

21

Start / End Page

768 / 769

Location

Orlando, FL

Publisher

AMER SOC HEMATOLOGY

Conference Name

52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Friedman, D. R., Davis, P. H., Lanasa, M. C., Moore, J. O., Gockerman, J. P., Nelson, T., … Weinberg, J. B. (2010). Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL). In BLOOD (Vol. 116, pp. 768–769). Orlando, FL: AMER SOC HEMATOLOGY.
Friedman, Daphne R., Patricia H. Davis, Mark C. Lanasa, Joseph O. Moore, Jon P. Gockerman, Taylor Nelson, Karen M. Bond, et al. “Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).” In BLOOD, 116:768–69. AMER SOC HEMATOLOGY, 2010.
Friedman DR, Davis PH, Lanasa MC, Moore JO, Gockerman JP, Nelson T, et al. Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL). In: BLOOD. AMER SOC HEMATOLOGY; 2010. p. 768–9.
Friedman, Daphne R., et al. “Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).” BLOOD, vol. 116, no. 21, AMER SOC HEMATOLOGY, 2010, pp. 768–69.
Friedman DR, Davis PH, Lanasa MC, Moore JO, Gockerman JP, Nelson T, Bond KM, Jiang N, Davis ED, Allgood SD, Chen Y, Sportelli P, Weinberg JB. Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL). BLOOD. AMER SOC HEMATOLOGY; 2010. p. 768–769.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 19, 2010

Volume

116

Issue

21

Start / End Page

768 / 769

Location

Orlando, FL

Publisher

AMER SOC HEMATOLOGY

Conference Name

52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology